Skip to content

InnovAge Holdings, Inc. INNV Tax receivable within other current assets

Tax receivable within other current assets at other companies

Astrana Health logo
Astrana HealthASTH

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+170%
Enterprise value$1.31B+143%
P/S1.4×+0.8×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesReceivable.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s tax receivable within other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s tax receivable within other current assets?
InnovAge Holdings, Inc. (INNV) reported tax receivable within other current assets of $3.39M in Q1 2026.
How has InnovAge Holdings, Inc.'s tax receivable within other current assets changed year-over-year?
InnovAge Holdings, Inc.'s tax receivable within other current assets increased by 1.9% year-over-year, from $3.32M to $3.39M.
What is the long-term trend for InnovAge Holdings, Inc.'s tax receivable within other current assets?
Over 4 years (2021 to 2025), InnovAge Holdings, Inc.'s tax receivable within other current assets has grown at a -11.5% compound annual growth rate (CAGR), from $5.4M to $3.31M.